Premium
Pharmacy Benefit Managers: Evaluating Clinical Utility in the Real World
Author(s) -
Epstein R S
Publication year - 2010
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2010.216
Subject(s) - pharmacy , clinical pharmacology , health care , broad spectrum , medicine , clinical pharmacy , medical education , family medicine , pharmacology , political science , chemistry , combinatorial chemistry , law
Over the years, pharmacy benefit managers (PBMs) have conducted and published peer‐reviewed research covering a broad spectrum of activities ranging from studying the impact of alternative‐benefit designs on outcomes to identifying the epidemiology of treated disease to understanding the impact of medication use on overall health‐care costs. 1 , 2 , 3 , 4 It is the unique “wired” interactive role in the health‐care system that enables PBMs to play an emerging role in evaluating the clinical utility of biomarkers. Clinical Pharmacology & Therapeutics (2010) 88 6, 880–882. doi: 10.1038/clpt.2010.216